MGCD Mgc Diagnostics Corp.

SAINT PAUL, Minn., June 2, 2017 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today announced that Todd Austin, Chief Executive Officer, will present at the 6^th Annual 2017 Marcum MicroCap Conference on Thursday, June 15, 2017 at 3:30 p.m. ET. The conference will be held at The Grand Hyatt Hotel in New York City.

The management of MGC Diagnostics will be available for one-on-one meetings at the conference on Thursday, June 15, 2017. Investors interested in arranging a meeting should contact a Marcum representative or call Lytham Partners at (602) 889-9700.

About the Marcum MicroCap Conference
The Marcum MicroCap Conference (www.marcummicrocap.com) is a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. The conference is attended each year by more than 2,000 investors and other participants from every segment of the microcap marketplace, including venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, and buy- and sell-side analysts, as well as senior executive teams from presenting companies and service providers to the microcap marketplace.

The conference is presented by Marcum LLP, a top national accounting and advisory firm registered with the Public Company Accounting Oversight Board (PCAOB). Marcum's Assurance Division provides the most up-to-date service and guidance on SEC accounting and reporting issues. Services include Financial Statement Audits in accordance with PCAOB standards; Tax Compliance and Advisory Services; Due Diligence; Agreed-Upon Procedures and Other Attest Work; Internal Audit Services; Sarbanes-Oxley Section 404 Compliance Services and Software; Technical Accounting Assistance; and IPO Assistance. For more information, visit www.marcumllp.com.

About MGC Diagnostics
MGC Diagnostics Corporation (NASDAQ: MGCD), is a global medical technology company dedicated to cardiorespiratory health solutions. The Company, through its Medical Graphics Corporation and Medisoft SA subsidiaries, develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and, in the United States, France and Belgium, primarily through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mgc-diagnostics-corporation-to-present-at-the-2017-marcum-microcap-conference-300467832.html

SOURCE MGC Diagnostics Corporation